0001807094-20-000028.txt : 20201216 0001807094-20-000028.hdr.sgml : 20201216 20201216105926 ACCESSION NUMBER: 0001807094-20-000028 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201216 DATE AS OF CHANGE: 20201216 EFFECTIVENESS DATE: 20201216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383356 FILM NUMBER: 201391548 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 D 1 primary_doc.xml X0708 D LIVE 0001175680 CytoDyn Inc. 1111 MAIN STREET, SUITE 660 VANCOUVER WA WASHINGTON 98660 360-980-8524 DELAWARE CYTODYN INC REXRAY CORP Corporation true Scott Kelly, M.D. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Director Nader Z Pourhassan, Ph.D 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Director Jordan G. Naydenov 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Alan P. Timmins 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Samir R. Patel, M.D. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Michael D. Mulholland 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Nitya G. Ray, Ph.D. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Mahboob Rahman, M.D., Ph.D. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Arian Colachis 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Biotechnology Decline to Disclose 06b false true true true true false 0 1176000 0 1176000 Offering related to the issuance of stock options to accredited investors to acquire 350,000 shares of common stock, at an exercise price of 3.36 per share, issued for compensatory purposes to service providers to the Company false 0 0 0 0 false CytoDyn Inc. Arian Colachis Arian Colachis VP, Secretary and General Counsel 2020-12-16